Monday, August 31, 2026
ExploreSearch
Via News
Markets

Li Auto Stock Slides 9% At Session Start On Wednesday, Underperforms Market

ViaNews Editorial Team

December 2, 2020

Li Auto Stock Slides 9% At Session Start On Wednesday, Underperforms Market
Shares of Li Auto dropped 9.18% to $31.66 at 09:41 EST on Wednesday, after three consecutive sessions in a row of losses. The Nasdaq Stock Market is rising 1.28% to $12,355.10, following yesterday's upward trend, on what at the moment seems, an all-around positive trend exchanging session today. Li Auto's last close was $35.99, 50.66% below its 52-week high of $47.70.

News about Li Auto today

According to today's article on MarketWatch, Li Auto's stock takes a dive after disclosing public offering of 47 million shares.

Li Auto's Stock Top and Bottom Yearly Value

Li Auto's stock is valued at $31.66 at 09:41 EST, way below its 52-week high of $47.70 and way above its 52-week low of $14.31.

Li Auto's Moving Average

Li Auto's worth is way above its 50-day moving average of $27.00 and way higher than its 200-day moving average of $20.95.

Categories

Markets

Tags

Stock MarketStockWall StreetStock PriceStock Market NowNASDAQMarket SessionIXICThe Nasdaq Stock MarketLi AutoLIStock Price Down
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com